Tech Company Financing Transactions
Aratana Therapeutics Funding Round
Aratana Therapeutics closed a $15 million Series B funding round on 12/7/2011. Backers included Avalon Ventures, Cultivian Sandbox and MPM Capital.
Transaction Overview
Company Name
Announced On
12/7/2011
Transaction Type
Venture Equity
Amount
$15,000,000
Round
Series B
Investors
Proceeds Purpose
The proceeds from the Series B financing will be used to expand the rich pipeline of innovative products that the company has already acquired. The additional resources allow for a more aggressive approach to in-license and develop novel medicines for dogs and cats.
Company Information
Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
1901 Olathe Blvd.
Kansas City, KS 66103
USA
Kansas City, KS 66103
USA
Phone
Website
Email Address
Not Recorded
Overview
Aratana Therapeutics develops innovative therapies for the animal health industry.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Steven Peter
Chief Scientific Officer
Linda Rhodes
Browse more venture capital transactions:
Prev: 12/7/2011: GiftRocket venture capital transaction
Next: 12/7/2011: LivingSocial venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on every notable VC transaction. VC transactions reported here are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs